Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.48 |
| ▸ | NPC1 | O15118 | 7/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 1/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LPL | P06858 | 2/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.40 |
| ▸ | ILK | Q13418 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1448847 | 0.83 | SNCA (0.66) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL732658 | 0.82 | SNCA (0.58) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL2748770 | 0.80 | PDGFRB (0.51) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL18015333 | 0.80 | KDM1A (0.48) | SNCADGAT1LPLLIPGCYP19A1 | |
| SCHEMBL21313409 | 0.79 | SNCA (0.55) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL2147093 | 0.79 | DGAT1 (0.45) | SNCADGAT1LPLLIPG | |
| SCHEMBL29081683 | 0.78 | KDM4E (0.52) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL2496185 | 0.77 | RAB9A (0.53) | RAB9ANPC1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL20068614 | 0.77 | DGAT1 (0.56) | DGAT1LPLLIPG | |
| SCHEMBL18859794 | 0.76 | DGAT1 (0.43) | SNCADGAT1LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616457-B1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| EP-2616457-B1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328086-B2 | Substituted bipyridines for use in organic light-emitting devices | NITTO DENKO CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| WO-2012037269-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120179089-A1 | SUBSTITUTED BIPYRIDINES FOR USE IN ORGANIC LIGHT-EMITTING DEVICES | BRD9, PIR, BRD2 | RAB9A 3592/4885NPC1 4104/4885KDM4E 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.